<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>escitalopram Archives - Gateway Psychiatric</title>
	<atom:link href="https://www.gatewaypsychiatric.com/tag/escitalopram/feed/" rel="self" type="application/rss+xml" />
	<link></link>
	<description>Excellent Psychiatric Care</description>
	<lastBuildDate>Wed, 07 Jul 2021 22:19:32 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://i0.wp.com/www.gatewaypsychiatric.com/wp-content/uploads/2013/06/favicon2.png?fit=32%2C32&#038;ssl=1</url>
	<title>escitalopram Archives - Gateway Psychiatric</title>
	<link></link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">70562394</site>	<item>
		<title>Functional Brain Imaging and Antidepressant Response</title>
		<link>https://www.gatewaypsychiatric.com/functional-brain-imaging-and-antidepressant-response/</link>
		
		<dc:creator><![CDATA[Peter Forster]]></dc:creator>
		<pubDate>Wed, 10 Feb 2016 04:33:45 +0000</pubDate>
				<category><![CDATA[Basic Science]]></category>
		<category><![CDATA[Testing]]></category>
		<category><![CDATA[Treatments of Depression]]></category>
		<category><![CDATA[antidepressant]]></category>
		<category><![CDATA[escitalopram]]></category>
		<category><![CDATA[functional brain imaging]]></category>
		<category><![CDATA[major depression]]></category>
		<category><![CDATA[outcomes]]></category>
		<category><![CDATA[prediction]]></category>
		<category><![CDATA[resting state fMRI]]></category>
		<category><![CDATA[sertraline]]></category>
		<category><![CDATA[snri]]></category>
		<category><![CDATA[ssri]]></category>
		<category><![CDATA[treatment response]]></category>
		<category><![CDATA[venlafaxine]]></category>
		<guid isPermaLink="false">https://www.gatewaypsychiatric.com/?p=10053</guid>

					<description><![CDATA[<p>One of the most exciting initiatives currently in the important area of  the treatment of depression is the International Study to Predict Optimized Treatment in Depression (iSPOT-D). This large multi-center initiative is based on a private industry and academic partnership that is designed to both identify best practices in the treatment of depression and also commercialize them. The most recent publication from this ... </p>
<div><a href="https://www.gatewaypsychiatric.com/functional-brain-imaging-and-antidepressant-response/" class="more-link">Read More</a></div>
<p>The post <a href="https://www.gatewaypsychiatric.com/functional-brain-imaging-and-antidepressant-response/">Functional Brain Imaging and Antidepressant Response</a> appeared first on <a href="https://www.gatewaypsychiatric.com">Gateway Psychiatric</a>.</p>
]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">10053</post-id>	</item>
		<item>
		<title>Escitalopram Reduces Inflammation in Depression</title>
		<link>https://www.gatewaypsychiatric.com/escitalopram-r-in-depression/</link>
		
		<dc:creator><![CDATA[Peter Forster]]></dc:creator>
		<pubDate>Sat, 05 Dec 2015 22:23:40 +0000</pubDate>
				<category><![CDATA[Major Depression]]></category>
		<category><![CDATA[Physical Conditions and Health]]></category>
		<category><![CDATA[Psychobiology]]></category>
		<category><![CDATA[Treatments of Depression]]></category>
		<category><![CDATA[c reactive protein]]></category>
		<category><![CDATA[crp]]></category>
		<category><![CDATA[escitalopram]]></category>
		<category><![CDATA[inflammation]]></category>
		<category><![CDATA[kynurenine]]></category>
		<category><![CDATA[major depression]]></category>
		<category><![CDATA[ssri]]></category>
		<guid isPermaLink="false">https://www.gatewaypsychiatric.com/?p=9453</guid>

					<description><![CDATA[<p>Escitalopram reduces inflammation in depression and potentially reduces neurotoxicity according to an article just published in the Journal of Psychiatric Research. A pro-inflammatory tendence has previously been noted in patients with depression, and this seems to be associated strongly with increases in kynurenine (see below for more information on how exercise counteracts this tendency). Kynurenine is the first step in ... </p>
<div><a href="https://www.gatewaypsychiatric.com/escitalopram-r-in-depression/" class="more-link">Read More</a></div>
<p>The post <a href="https://www.gatewaypsychiatric.com/escitalopram-r-in-depression/">Escitalopram Reduces Inflammation in Depression</a> appeared first on <a href="https://www.gatewaypsychiatric.com">Gateway Psychiatric</a>.</p>
]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">9453</post-id>	</item>
	</channel>
</rss>
